CVAC 241220 3.00P (CVAC241220P3000) Stock Options, News & Quotes

$CureVac (CVAC.US)$ CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data
at ESMO 2024 Congress

TÜBINGEN, Germany/BOSTON, USA – September 9, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that the first clinical data from CureVac’s ongoing Phase 1 CVGBM cancer vaccine study in patients with rese...

Trytosaveabit

Aug 15 16:37

Update! Make a note for the date in last sentence! GSK has partnered in this! Good enough for GSK! I guess good enough for me? Hehehe

$CureVac (CVAC.US)$
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study
in Patients with Resected Glioblastoma

·First patient administered in dose-confirmation Part B of Phase 1 study with mRNA-based, multiepitope cancer vaccine candidate CVGBM
·Part B expected to include up to 20 patients to generate extended data on safety, tolerabil...

Mr 蓝波湾

Jul 16 21:42

Update on my holds

Share Your Profit/Loss

Trytosaveabit

Jul 11 12:52

Gettin a lil bita juice from that IMO bullish PR

$CureVac (CVAC.US)$ 🤫💸